Faith-Based Investors To Pressure Drug Companies To Provide Less-Expensive Medications, Including Antiretrovirals

Main Category: Pharma Industry / Biotech Industry
Article Date: 30 Mar 2005 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


An association of 275 faith-based institutional investors -- who control an estimated $110 billion in assets -- plan to introduce shareholder resolutions at annual meetings of pharmaceutical companies to pressure the companies to provide lower-cost medications, including HIV/AIDS drugs,... Long Island Newsday reports. The Interfaith Center on Corporate Responsibility will call on pharmaceutical companies Abbott Laboratories, Bristol-Myers Squibb, Merck, Pfizer, Eli Lilly, Wyeth and Gilead Sciences to "analyze the impact" of HIV/AIDS on their business practices, disclose political contributions made with corporate funds, and separate the roles of board chair and CEO to allow for independent oversight, according to Newsday. The Interfaith Center focuses its criticism on the business model of developing a small number of "blockbuster drugs," according to Newsday. According to the Pharmaceutical Research and Manufacturers of America, the industry in 2004 invested about $38.8 billion in research and development and about $4 billion on direct-to-consumer advertising. "They should make sure accessibility to their drugs grows, expanding their customer base," Interfaith Center advocate Margaret Weber said, adding, "Shareholders who depend on the companies' doing well have concerns. From a business standpoint, we are not convinced that the current model is sustainable." Critics of the Interfaith Center's view say that the intention of changing business models is "laudable," but the plan likely would "drag down" performance of investment funds and reduce payments to retirees, Newsday reports (Zehren, Long Island Newsday, 3/27).

"Reprinted with permission from kaisernetwork.org kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv.. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "Faith-Based Investors To Pressure Drug Companies To Provide Less-Expensive Medications, Including Antiretrovirals." Medical News Today. MediLexicon, Intl., 30 Mar. 2005. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/21979.php>

APA
Christian Nordqvist. (2005, March 30). "Faith-Based Investors To Pressure Drug Companies To Provide Less-Expensive Medications, Including Antiretrovirals." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/21979.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »